Boai NKY Medical Holdings Ltd. (SHE:300109)
18.86
-0.30 (-1.57%)
Feb 13, 2026, 3:04 PM CST
Boai NKY Medical Holdings Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 |
Net Income | 239.53 | 349.68 | 493.03 | 291.46 | 207.05 | 44.57 |
Depreciation & Amortization | 95.77 | 95.77 | 74.22 | 61.94 | 71.88 | 52.46 |
Other Amortization | 9.26 | 9.26 | 4.77 | 3.9 | 4.32 | 3.81 |
Loss (Gain) From Sale of Assets | -0.09 | -0.09 | -0.04 | 0.87 | 0.46 | 0.83 |
Asset Writedown & Restructuring Costs | 46.37 | 46.37 | 0.36 | 0.11 | 60.63 | 40.28 |
Loss (Gain) From Sale of Investments | 12.23 | 12.23 | 1.07 | 37.83 | -201.64 | -2.55 |
Provision & Write-off of Bad Debts | - | - | 9.61 | 45.82 | 11.7 | 25.72 |
Other Operating Activities | 46.96 | 6.49 | -5.03 | -2.25 | 36.49 | 23.11 |
Change in Accounts Receivable | -27.84 | -27.84 | -57.81 | -163.95 | 9.25 | 38.59 |
Change in Inventory | -71.62 | -71.62 | -61.94 | -10.26 | -39.3 | -1.75 |
Change in Accounts Payable | -181.52 | -181.52 | 32.27 | 10.25 | -104.68 | 42.79 |
Change in Other Net Operating Assets | 28.58 | 28.58 | -4.23 | -3.7 | -0.63 | 0.65 |
Operating Cash Flow | 186.35 | 256.03 | 488.25 | 251.77 | 43.44 | 266.87 |
Operating Cash Flow Growth | -56.34% | -47.56% | 93.93% | 479.57% | -83.72% | 235.10% |
Capital Expenditures | -249.37 | -274.68 | -377.88 | -266 | -228.32 | -99.24 |
Sale of Property, Plant & Equipment | 3 | 0.04 | 0.17 | 0.42 | 15.81 | 3.1 |
Cash Acquisitions | - | - | - | - | - | 0.53 |
Divestitures | 0.25 | 4.95 | 8.93 | 0 | 1,970 | 0.03 |
Investment in Securities | 210.31 | 174.56 | -175.86 | 549.93 | 254.98 | -10.9 |
Other Investing Activities | 291.1 | - | - | -587.08 | -482.5 | 0.06 |
Investing Cash Flow | 255.29 | -95.14 | -544.64 | -302.72 | 1,530 | -106.42 |
Long-Term Debt Issued | - | 626.79 | 14.98 | 26.68 | 607.68 | 733.19 |
Total Debt Issued | 532.44 | 626.79 | 14.98 | 26.68 | 607.68 | 733.19 |
Short-Term Debt Repaid | - | - | - | - | -30 | - |
Long-Term Debt Repaid | - | -238.43 | -27.34 | -36.33 | -1,289 | -765.41 |
Total Debt Repaid | -659.79 | -238.43 | -27.34 | -36.33 | -1,319 | -765.41 |
Net Debt Issued (Repaid) | -127.35 | 388.35 | -12.37 | -9.65 | -711.66 | -32.22 |
Issuance of Common Stock | 1.29 | 0.9 | - | 15.1 | 119.4 | - |
Repurchase of Common Stock | -1.9 | -1.9 | -7.08 | -400.07 | -3.4 | - |
Common Dividends Paid | -126.57 | -328.78 | -164.26 | -169.97 | -41.49 | -56.13 |
Other Financing Activities | 0.06 | 0.06 | - | - | - | -70.21 |
Financing Cash Flow | -254.47 | 58.63 | -183.71 | -564.59 | -637.15 | -158.56 |
Foreign Exchange Rate Adjustments | 6.88 | 4.87 | 2.02 | 3.86 | 2.58 | -4.94 |
Net Cash Flow | 194.04 | 224.4 | -238.07 | -611.68 | 938.42 | -3.04 |
Free Cash Flow | -63.02 | -18.65 | 110.37 | -14.23 | -184.88 | 167.63 |
Free Cash Flow Margin | -4.36% | -1.16% | 6.97% | -0.96% | -15.15% | 17.13% |
Free Cash Flow Per Share | -0.13 | -0.04 | 0.23 | -0.03 | -0.37 | 0.35 |
Cash Income Tax Paid | 92.72 | 83.63 | 240.09 | 147.89 | 62.9 | 66.86 |
Levered Free Cash Flow | -39.49 | -72.55 | 24.6 | -25.77 | 136.38 | 212.6 |
Unlevered Free Cash Flow | -34.52 | -68.15 | 25.89 | -24.13 | 159.96 | 244.83 |
Change in Working Capital | -263.69 | -263.69 | -89.73 | -187.92 | -147.44 | 78.63 |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.